Femtech, or women’s health technology, is among the most rapidly growing and well-funded areas of digital health. Femtech is a broad term that refers to a variety of digital health applications and tech-enabled service providers that cater to women’s biological needs.
New York, July 01, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Femtech Market Size, Share & Industry Trends Analysis Report By Product Type, By Mobile Apps Type, By Regional Outlook and Forecast, 2022 – 2028" - https://www.reportlinker.com/p06289245/?utm_source=GNW These requirements range from general well-being through reproductive health, which includes fertility, pregnancy, and nursing care. Maternal and child care, family planning, fertility, and menstrual cycles are among the femtech sectors, but so are other biological devices and applications that deal with invasive reproductive health. Companies of smart wearable gadgets and advanced mobile application developers are combining their unique product development tactics to better serve women’s health demands. Female users can effortlessly track their health and wellbeing, obtain instructional content on a variety of health topics, and take an active role with female communities or healthcare experts using various applications and devices (wearable and non-wearable). Natural Cycles, for example, received FDA approval and authorization in July 2021 to use body temperature data acquired by smart wearables, such as the Oura smart ring, to assess a woman’s fertility and manage pregnancy. Virtual clinics like Tia, an innovative brick-and-mortar clinic like Kindbody, and direct-to-consumer prescription delivery services such as the Pill Club all make it easier for women to get care in a more convenient and consumer-centric way. Allowing for self-care: FemTech solutions such as Bloomlife’s trackers and wearables, as well as Modern Fertility’s at-home tests, are among some of the FemTech solutions which are helping women take control of their healthcare and health-related data. COVID-19 Impact The outbreak of the COVID-19 pandemic has impacted every domain of the business world. The imposition of various regulations like partial or complete lockdown, temporary ban on manufacturing units, and restrictions on imports or exports has disrupted the operations of numerous verticals. On the other hand, the digitalization across industries has witnessed a rapid pace, which is further contributing to the demand for numerous advanced solutions and applications like femtech. Pharmaceutical and biotech businesses, in collaboration with governments around the world, are working to combat the COVID-19 outbreak, from vaccine development to pharmaceutical supply chain planning. Market Growth Factors Growing cases of lifestyle diseases among women would augment the market growth COVID-19 has had a major positive impact on the Femtech market as a result of various lifestyle disorders affecting women’s health. During the pandemic, women’s health concerns grew, including reproductive disease, mental health, and a greater risk of acquiring metabolic syndrome and other chronic diseases as a result of changing lifestyle patterns. Miscarriages, stillbirths, and birth problems are common throughout pregnancy, leading to worry, melancholy, and hormone imbalance. Increasing adoption of digital healthcare solutions The increased demand for egg freezing, embryo screening, fertility, and other services has resulted from the breakthrough femtech solutions. In addition, the development of wearable gadgets to track and monitor patient well-being will boost usage in the future years. The availability of such technologically advanced gadgets would compel key market players to introduce innovate solutions and applications in the market, which offers better care for women. Along with that, the growing investment by the governments across nations in the advancements of the healthcare system would boost the demand for these solutions. Market Restraining Factors Dearth of awareness about femtech products & solutions among women living in remote areas Despite all of the advances achieved in the digital world, femtech still confronts numerous hurdles. In comparison to women living in rural & remote locations, women in metropolitan areas tend to have access to the internet and mobile phone coverage. It is far easier to reach educated people who are more open to change than it is to reach the bulk of population who lack access to education and hence are unable to accept the rapid changes that are occurring. New-age, female-oriented digital health enterprises must mobilise efforts to reach out to women in the general population. Product Type Outlook Based on Product Type, the market is segmented into Wearables and Mobile Apps. Based on Mobile Apps Type, the market is segmented into Fitness & Nutrition, Menstrual Health, Fertility Management/ Assisted Reproductive Technology Apps, Pregnancy Tracking & Postpartum Care, Menopause, Disease Management, and Others. The wearables segment recorded the highest revenue share in the femtech market in 2021. It is due to the increasing health awareness among women and the rising cases of women’s health condition. In addition, the growth of this segment is being fueled by a shift toward value-based care and a consumer-driven paradigm. Furthermore, as the population focuses more and more on self-health care, wellness, and digitalization, wearable technologies are evolving and serving as a crucial tool. Wearables are projected to grow in popularity due to rapid developments in design. Some of the biggest advancements in wearable technology include cloud synchronisation, predictive analytics, and gamification. Regional Outlook Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America emerged as the leading region in the femtech market with the maximum revenue share in 2021. It is owing to the swift pace of digitalization of healthcare products and solutions across various nations of the region. The expansion of the North American femtech market is predicted to be driven by increasing usage of smart wearable devices and mobile health applications for health tracking, as well as rising health consciousness and awareness and a shift toward preventive care. Furthermore, favourable government initiatives, rising healthcare IT investment, and the advancement of digital health infrastructure are all boosting market expansion The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Google LLC, HeraMED Ltd., iSono Health, Inc., Clue by Biowink GmbH, Chiaro Technology Ltd., Natural Cycles USA Corp., Flo Health UK Limited, Glow, Inc., and Withings France SA. Strategies Deployed in Femtech Market Mar-2022: Elvie, a subsidiary of Chiaro Technology Ltd., introduced Elvie Stride Plus, featuring a new breast pump, Elvie Stride, along with a 3-in-1 Carry Bag. Elvie Stride Plus would offer more women access to its advanced breast pumping solutions. Jan-2022: Withings launched its Body Scan in-home connected health station smart scale platform. The Body Scan include various things beyond weight management to provide a way for customers to take proactive control over their health with segmental body composition, heart rate, and vascular age monitoring. Aug-2021: Clue formed a partnership with L’Oréal, a French personal care company. This partnership aimed to strengthen knowledge of the relationship between skin health and the menstrual cycle. This collaboration bridges L’Oréal’s historic skincare expertise and beauty-tech ambitions with Clue’s leadership in reproductive health and data-driven technology. Jul-2021: Natural Cycles received approval from FDA to combine third-party thermometers including consumer wearables into its app to assist pinpoint a customer’s fertility status. Body temperature would be a component of Natural Cycles’ calculations from the beginning of its launch in the market. Jun-2021: Glow unveiled its erotic app for Android and Apple devices. Through this app, Glow would seek to improve sexual wellness via guided meditation soundscapes developed to ignite the imagination. Mar-2021: Clue got clearance from the Food and Drug Administration for a digital birth control function. This function would assist users to prevent pregnancy based only on the start date of a user’s period. It also evaluates the window where someone would get pregnant based on statistical modeling. Dec-2020: HeraMED came into a partnership with Teleperinatal, a maternity telehealth service. This partnership aimed to implement the HeraCARE mobile maternal care app and the HeraBEAT smart fetal HR monitor, within an initial paid pilot for six months. Jul-2020: HeraMED extended its collaboration with Mayo Clinic, a nonprofit American academic medical center. The extended collaboration would provide patients utilizing the HeraMED platform access to Mayo’s library of educational content while Mayo’s clinicians study the deployment of its HeraCARE platform. May-2020: Fitbit, a Google company, acquired Twine Health, an innovative, proven health coaching platform. This acquisition aimed to expand the reach of Fitbit into healthcare and lay the foundation to expand its portfolio to health plans, health systems, and self-insured employers, along with opening the opportunities to boost subscription-based revenue. May-2019: HeraMED signed a Memorandum of Understanding (MOU) with IBL Holding, an Israel-based company with established retail partners in Mexico. This MoU aimed to progress a pilot trial to sell HeraBEAT medical grade fetal heart rate monitors in Mexico. Aug-2018: Natural Cycles received approval from FDA for its Natural Cycles, an app that claims to be able to help prevent pregnancy. Through this approval, the government agency would establish criteria and guidelines, which would pave the way for a new category of apps that are utilized as digital contraception. Aug-2018: Elvie, a subsidiary of Chiaro Technology Ltd., entered into a partnership with the UK’s National Health Service. Through this partnership, Elvie’s device would be available across the nation via the country’s free-at-the-point-of-use healthcare service so at no direct cost to the patient. Mar-2018: Fitbit, a Google company, introduced the Versa, a woman-focused smartwatch. The waterproof Versa would calculate heart rate, carry on the usual fitness tracking metrics, and allow women to monitor their menstrual cycle. Scope of the Study Market Segments covered in the Report: By Product Type • Wearables • Mobile Apps o Fitness & Nutrition o Menstrual Health o Fertility Management/ Assisted Reproductive Technology Apps o Pregnancy Tracking & Postpartum Care o Menopause o Disease Management o Others By Geography • North America o US o Canada o Mexico o Rest of North America • Europe o Germany o UK o France o Russia o Spain o Italy o Rest of Europe • Asia Pacific o China o Japan o India o South Korea o Singapore o Malaysia o Rest of Asia Pacific • LAMEA o Brazil o Argentina o UAE o Saudi Arabia o South Africa o Nigeria o Rest of LAMEA Companies Profiled • Google LLC • HeraMED Ltd. • iSono Health, Inc. • Clue by Biowink GmbH • Chiaro Technology Ltd. • Natural Cycles USA Corp. • Flo Health UK Limited • Glow, Inc. • Withings France SA Unique Offerings • Exhaustive coverage • Highest number of market tables and figures • Subscription based model available • Guaranteed best price • Assured post sales research support with 10% customization free Read the full report: https://www.reportlinker.com/p06289245/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
The U.S. is gearing up for another wave of COVID-19 infections in the fall and winter following a flurry of activity this week.
Kristin Cavallari shared a new photo of herself in a bikini, showing off the fitness progress she has made since dedicating herself to a healthier lifestyle.
Now that Q2 has come to end, the focus on Wall Street will turn to the second quarter results. In Apple’s (AAPL) case, the past 3 months have been defined by the Covid lockdowns in China which will adversely affect revenue by between $4 billion and $8 billion. However, recent checks made by Wedbush analyst Daniel Ives regarding the Asia iPhone supply chain indicate that over the past few weeks the situation has been “steady with slight improvements.” “As of now we believe iPhone demand is holdin
Internet search history, text messages and location data could take on new significance for people seeking information about abortion services after the overturning of Roe v. Wade.
(Bloomberg) -- Elon Musk’s SpaceX won permission from US regulators to offers its Starlink broadband-from-space service to users in vehicles, vessels and aircraft.Most Read from BloombergCrypto Meltdown Claims Rolex and Patek Philippe as VictimsUS Will Face High Gas Prices ‘as Long as It Takes,’ Biden SaysHow Europe Became the Epicenter for This Summer’s Travel ChaosThe Wheels Have Come Off Electric VehiclesNetflix Crashes After ‘Stranger Things 4’ Finale ReleaseThe Federal Communications Commis
Is Johnson & Johnson stock a buy after the company unveiled positive results in cancer treatment this month? Is JNJ stock a buy?
The Los Angeles-based company is far different from Athenex, developing different kinds of cancer drugs and building its own business model around those plans, but it also has some notable similarities.
Nearly 20 years after Athenex was commercialized out of chemist David Hangauer's University at Buffalo lab, the U.S. Food and Drug Administration swung its hammer. The FDA ruled in February 2021 that Athenex’s leading therapy – an oral formulation of popular chemotherapy drug that proposed to be both more effective and less toxic – needed to undergo a new clinical trial before it was fully approved. Athenex stock has tumbled from $12 at that time to less than $1 now.
Officials say it’s circulating and a matter of time before a case is reported.
The FDA is asking COVID-19 vaccine makers to test and produce boosters that target both the original and new BA.4/BA.5 strains of the virus by fall.
U.S. regulators are telling COVID-19 vaccine makers to tweak any booster doses intended for fall so they protect against the newest omicron relatives
Gut health is important for so many reasons! First of all, when the gut is unhealthy it can lead to a variety of digestive symptoms such as heartburn, abdominal pain, bloating, excess gas, constipation, and diarrhea, just to name a few. These symptoms can be very disruptive to daily life and can get in the way of work, school, relationships, and even enjoying a normal meal. Another reason it's important to have a healthy gut is that the gut is connected to so many other body systems. For this re
Fighting with family and friends about the SCOTUS decision can feel hopeless. Here’s how to be heard while staying sane.
"As the Covid pandemic continues to evolve and be highly unpredictable, we must remain vigilant in protecting those who are at greatest risk of getting very sick from Covid," said CEO Albert Bourla.
Philip Burdett, 59, to spend three years behind bars for gross negligence manslaughter, while his father Ralph, 93, handed suspended prison term
The U.S. Food and Drug Administration on Thursday recommended COVID-19 vaccine manufacturers change the design of their booster shots beginning this fall to include components tailored to combat the currently dominant Omicron BA.4 and BA.5 subvariants of the coronavirus. If authorized, the changes would mark the first major retooling of COVID vaccines, but also could slow their rollout as the FDA has recommended a design somewhat different from what the companies had already tested and started producing. The FDA will not require new studies testing the BA.4/BA.5 shots in humans to be completed for authorization, a top agency official told Reuters, similar to how annual changes to flu vaccines are handled.
Shanna Moakler released a statement on Travis Barker's hospitalization, praising Kourtney Kardashian.
The current strain on the foster care system nationwide is evident and creates a lack of stability for children in the system.
(Bloomberg) -- Micron Technology Inc. gave a surprisingly downbeat forecast for the current quarter after demand for phones and computers weakened, but vowed to move aggressively to stave off a chip glut. Most Read from BloombergUS Will Face High Gas Prices ‘as Long as It Takes,’ Biden SaysStock Doomsayers Vindicated in Historic First Half: Markets WrapThe Wheels Have Come Off Electric VehiclesDemocrats Weigh Paring Biden Tax Hike to Win Over ManchinUkraine Latest: Kyiv Lauds Isle Retake; Putin
Viruses evolve, and vaccines should too. That was the big-picture takeaway from a pivotal meeting this week of the FDA’s expert advisory panel. The question before them was simple: Ahead of an expected winter surge, should vaccine manufacturers tweak their forthcoming booster shots to target Omicron, or should they stick with the tried-and-true 2020 recipe?